Skip to main content
OpenTrials

Clinical trial condition

Lung Diseases, Interstitial

Explore clinical trials studying Lung Diseases, Interstitial. Study availability and eligibility vary by location and protocol.

440 public trials 128 recruiting studies
Refine in advanced search Browse all conditions

Lung Diseases, Interstitial trial results

Completed

Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis

NCT05415137

Conditions
Fibrosis, Granuloma, Hemic and Lymphatic Diseases, +15 more
Locations
  • aTyr Investigative Site Birmingham, Alabama, United States
  • aTyr Investigative Site Phoenix, Arizona, United States
  • aTyr Investigative Site Los Angeles, California, United States
  • aTyr Investigative Site Sacramento, California, United States
View all 91 locations
View Trial Details
Completed

Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection

NCT05776225

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +6 more
Locations
  • Pulmonary Associates Phoenix, Arizona, United States
  • Hartford Hospital Hartford, Connecticut, United States
  • Lakeland Regional Health Lakeland, Florida, United States
  • NCH Healthcare System Naples, Florida, United States
View all 42 locations
View Trial Details
Completed

BPF Genetics of ILD Study

NCT03747627

Conditions
Alveolitis, Extrinsic Allergic, Bird Fancier's Lung, Disease, +14 more
Locations
  • Royal Pigeon Racing Association Meeting Blackpool, United Kingdom
  • Scottish Homing Union Lanark, United Kingdom
View Trial Details
Completed

Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

NCT04708782

Conditions
Idiopathic Pulmonary Fibrosis, Interstitial Lung Disease, Lung Diseases, +3 more
Locations
  • The University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner University Medical Center-Phoenix Phoenix, Arizona, United States
  • Arizona Pulmonary Specialists, Ltd. Phoenix, Arizona, United States
  • St. Joseph's Hospital and Medical Center - Norton Thoracic Institute Phoenix, Arizona, United States
View all 98 locations
View Trial Details
Completed

The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

NCT04619680

Conditions
COVID-19, Cicatrix, Coronaviridae Infections, +18 more
Locations
  • Emory Healthcare Network Atlanta, Georgia, United States
  • The Johns Hopkins Hospital Baltimore, Maryland, United States
  • Mount Sinai Beth Israel New York, United States
  • Icahn School of Medicine at Mount Sinai New York, United States
View Trial Details
Completed

An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

NCT05649722

Conditions
Cardiovascular Diseases, Hypertension, Hypertension, Pulmonary, +6 more
Locations
  • ARG003 Autonomus City of Buenos Aires, Buenos Aires, Argentina
  • ARG001 Rosario, Santa Fe Province, Argentina
  • AUS005 Macquarie Park, New South Wales, Australia
  • BEL002 Liège, Belgium
View all 22 locations
View Trial Details

Related conditions